Will the coal ETF stabilize after a one or two-week correction on the weekly chart? Can Lens Technology's 5 billion performance forecast save the day?

When it comes to pullbacks, it always makes people think of Lens Technology. In the consumer electronics sector, everyone knows that when Apple releases a new device, the supply chain follows suit and rises. But Lens Technology has been stumbling over the past two years. After dropping from its high point, it finally found a bottom, and now it’s oscillating again. Looking at the daily chart, the correction phase isn’t fully over yet. The fundamentals are actually quite good; institutions forecast that by 2025, net profit could reach over 5 billion yuan, with earnings per share close to 1 yuan, up about 40% year-over-year. These numbers are impressive and tell a compelling story. Think about it—small items like phone cases and screen protectors hide a lot of technical expertise. Lens has evolved from glass processing to liquid metal, thermal solutions, and is now venturing into robot parts and liquid cooling for servers. Their transformation is making big strides. But market sentiment can change suddenly. In the short term, stock prices fluctuate wildly. Isn’t that testing investors’ patience?

Now, let’s look at Tiantan Biological. In the blood products industry, the barriers to entry are extremely high—resources for plasma stations and production scale are both essential. When viewed over a longer timeframe, the stock has been hitting lows for several years. It’s only recently stabilized, but the performance forecast isn’t very bright. Net profit in 2025 is expected to be around 1.5 billion yuan, slightly lower than the previous year. Why is that? Product prices are under pressure, and although sales are growing, profits are being diluted. The overall environment in the biotech sector isn’t easy either—new drug approvals and centralized procurement keep everyone on edge. But on the flip side, the demand for medical services is a necessity. With aging populations and increasing healthcare needs, Tiantan Biological still has a solid foundation. If they can weather the storm, there might be a bright future ahead.

Looking at these three sectors together, they all operate under the same broad context: cyclical stocks are correcting, growth stocks are oscillating, and essential stocks remain stable but under pressure. Coal is heavily influenced by weather and international factors; Lens Technology is tied to the consumer electronics cycle; Tiantan Biological faces regulatory uncertainties. No one can guarantee which will take off tomorrow, but isn’t that just life? Opportunities often hide when others hesitate.

Have you ever wondered why some people always find opportunities in pullbacks? Maybe it’s because they don’t just look at prices—they look at the stories behind them. Lens Technology shipped thousands of humanoid robots and over ten thousand quadruped robots. Those numbers sound exciting, even if they haven’t yet turned into profits. But the direction is right. On the coal side, supply growth is expected to slow down by 2026, with significant room for demand improvement. The expectation that coal prices will gradually rise isn’t unfounded. As for Tiantan Biological, holding onto plasma station resources could pay off in the long run—there’s always a chance for a turnaround.

Of course, the stock market is never a charity. During corrections, emotions are the easiest to lose. Some rush to buy the dip and end up trapped; others hold on stubbornly and miss the rebound. Details determine success or failure. For example, when Lens Technology’s stock approaches a resistance level, did the trading volume increase? Did the weekly indicators for coal ETFs show divergence? These small signals are often more useful than grand theories.

Ultimately, investing boils down to understanding the industry and controlling your own emotions. Currently, market hot spots rotate quickly—coal, consumer electronics, biotech—all have their own logic. Those who can stay calm and think carefully might find the next opportunity hidden in these pullbacks. What do you think? Among these stocks, which one do you believe will break out first? Or do you have similar situations with your holdings and are debating whether to wait a bit longer?